{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T02:49:30Z","timestamp":1720320570382},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jcv.2014.11.013","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T10:40:32Z","timestamp":1416307232000},"page":"66-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids"],"prefix":"10.1016","volume":"62","author":[{"given":"Corentin","family":"Orvain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Ducancelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Eymerit-Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Oberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Hunault-Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Tanguy-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2014.11.013_bib0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/asheducation-2008.1.450","article-title":"Disease-specific complications of chronic lymphocytic leukemia","author":"Dearden","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jcv.2014.11.013_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jcv.2014.11.013_bib0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/clinids\/24.3.334","article-title":"Herpes simplex virus hepatitis: case report and review","volume":"24","author":"Kaufman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2014.11.013_bib0020","series-title":"Les h\u00e9patites virales non alphab\u00e9tiques","author":"Bourliere","year":"2004"},{"key":"10.1016\/j.jcv.2014.11.013_bib0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1067\/mjd.2003.94","article-title":"Atypical recurrent varicella in 4 patients with hemopathies","volume":"48","author":"Nikkels","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jcv.2014.11.013_bib0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00007890-199907150-00030","article-title":"Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil","volume":"68","author":"Rothwell","year":"1999","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jcv.2014.11.013_bib0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08880010801938215","article-title":"Fatal visceral varicella-zoster virus infection without skin involvement in a child with acute lymphoblastic leukemia","volume":"25","author":"Matsuzaki","year":"2008","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jcv.2014.11.013_bib0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/10428199409056283","article-title":"Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment","volume":"13","author":"Molica","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcv.2014.11.013_bib0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3109\/10428194.2012.755178","article-title":"Viral infections and their management in patients with chronic lymphocytic leukemia","volume":"54","author":"Melchardt","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcv.2014.11.013_bib0050","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1182\/blood.V95.9.2786.009k30_2786_2792","article-title":"Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features","volume":"95","author":"Mauro","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2014.11.013_bib0055","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1200\/JCO.2001.19.16.3611","article-title":"Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011","volume":"19","author":"Morrison","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcv.2014.11.013_bib0060","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-2141.2003.04497.x","article-title":"Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia","volume":"122","author":"Hensel","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcv.2014.11.013_bib0065","first-page":"1145","article-title":"Multiple lines of chemotherapy are the main risk factor for severe infections in patients with chronic lymphocytic leukemia with febrile episodes","volume":"90","author":"Molteni","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jcv.2014.11.013_bib0070","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1080\/1042819031000110991","article-title":"Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia","volume":"44","author":"Shvidel","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcv.2014.11.013_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2141.2006.06382.x","article-title":"Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukemia during fludarabine-based first line therapy","volume":"136","author":"Eichhorst","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcv.2014.11.013_bib0080","first-page":"121","article-title":"Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study","volume":"81","author":"Molica","year":"1996","journal-title":"Haematologica"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214004211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653214004211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T23:55:45Z","timestamp":1598486145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653214004211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":16,"alternative-id":["S1386653214004211"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2014.11.013","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroids","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2014.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}